In June 2021, the U.S. Nuclear Regulatory Commission approved a license amendment request for Centrus to enrich uranium up to a Uranium-235 concentration of 20 percent, making it the first U.S. facility licensed for HALEU production. This is higher than the 5 percent level found in Low-Enriched Uranium that is used in existing light-water reactors.
